Know Cancer

forgot password

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

18 Years
50 Years
Open (Enrolling)
Breast Cancer, Lymphoma, Hodgkin's Lymphoma

Thank you

Trial Information

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

Inclusion Criteria:

- Premenopausal women at time of diagnosis ages 18 to 50 who have either been pregnant
or had at least one menstrual period in the last 12 months

- Women with newly diagnosed breast cancer (stage 0-III) or Diffuse Large B-cell
Lymphoma or Hodgkin's Lymphoma within 1 month of starting systemic treatment

- Breast cancer patients with any receptor type

- English speaking

- Able to participate in the informed consent process

Exclusion Criteria:

- Active secondary cancer requiring cytotoxic chemotherapy

- Prior systemic treatment for a malignancy

Type of Study:


Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

determine the natural history of sexual and reproductive health

Outcome Time Frame:

5 years

Safety Issue:


Principal Investigator

Shari Goldfarb, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center


United States: Institutional Review Board

Study ID:




Start Date:

February 2013

Completion Date:

February 2016

Related Keywords:

  • Breast Cancer
  • Lymphoma
  • Hodgkin's Lymphoma
  • Sexual and Reproductive Health
  • premenopausal
  • Fertility
  • 12-249
  • Breast Neoplasms
  • Hodgkin Disease
  • Lymphoma



Memorial Sloan Kettering Cancer CenterNew York, New York  10021
Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital CenterSleepy Hollow, New York  10591
Memorial Sloan-Kettering at Basking RidgeBasking Ridge, New Jersey  07920
Memorial Sloan-Kettering Cancer Center @ SuffolkCommack, New York  11725
Memorial Sloan-Kettering at Mercy Medical CenterRockville Centre, New York